(MedPage Today) -- Patients with primary progressive multiple sclerosis (PPMS) who took interferon-beta-1b for two years in a randomized trial continued to show improvement relative to placebo-treated patients five years later, Spanish researchers said.
Benefit Seen With Interferon Lasts in Progressive MS (CME/CE)
Tue, 15 Nov 2011 20:58:09 GMT
No comments:
Post a Comment